Side by side: size, value over time, results, valuation, margins, growth, debt and shareholder returns, and any of thirty figures charted over the years (up to 6).
Open these as a peer group: up to 12 companies with suggested peers, each company's rank in the group and percentile in its sector and country, saved for you or your team.
US$ billions, as reported in each year's annual results.
Revenue of the fiscal year. US dollars at each year's exchange rate.
| Measure | Poxel S.A.✕ POXEL.PA |
|---|---|
| Profile | |
| Country | 🇫🇷 France |
| Sector | Healthcare |
| Industry | Biotechnology |
| Founded | — |
| Size | |
| Revenue | $7 M |
| Net income | $-20 M |
| Profitability | |
The largest companies, each against its nearest peers in value from the same industry.
| Fiscal year | Poxel S.A. |
|---|---|
| 2024 | $7 MESEF |
| 2023 | $2 MESEF |
Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports; Ed. = the company's report (editors); WD = Wikidata, citing the annual report; Cap = value.today market caps. Hover a figure for its period.
| Gross margin | 55.7% |
|---|
| Operating margin | -52.8% |
|---|
| Net margin | -275.9% |
|---|
| Growth | |
|---|---|
| Revenue growth | 235.5% |
| Altman Z-score zone | — |
|---|
| Data as of | Market cap Jan 2024; ratios FY2024 |
|---|
Market caps from exchange data or SEC filings on the date shown (* last known value, no current one); revenue and net income from the latest annual results; ratios worked out from each company's own statements for the fiscal year shown. ▲ marks the best of these companies where higher or lower is better; size and valuation multiples are marked for no one. Definitions: methodology.